Latest News
CHOSA Oncology signs US laboratory agreement for Platin-DRP commercialisation
4 November 2026 - Swedish precision oncology company CHOSA Oncology AB (Spotlight Stock Market: CHOSA) said on Wednesday it has signed an agreement with a CLIA-certified laboratory to develop and validate Platin-DRP as a laboratory-developed test for...
Agilent acquires Proscia for USD240m
4 November 2026 - Agilent Technologies Inc (NYSE: A), a provider of analytical and clinical laboratory technologies, announced on Wednesday that it has completed its acquisition of digital-pathology software provider Proscia for USD240m in cash, with...
BeOne Medicines wins FDA Priority Review for BRUKINSA combination in first-line mantle cell lymphoma
4 November 2026 - Oncology company BeOne Medicines Ltd (Nasdaq: ONC) (HKEX: 06160) (SSE: 688235) reported on Wednesday that it has received US Food and Drug Administration (FDA) Priority Review for its application to use BRUKINSA (zanubrutinib) with ...
United Therapeutics eliminates Pfizer royalty obligations on ralinepag for USD525m
4 November 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Wednesday that it has entered into an amended agreement with Arena Pharmaceuticals, a subsidiary of Pfizer Inc (NYSE:PFE), to eliminate all royalty obl...
Sectra wins seven-year radiology reporting contract with Mount Sinai Health System
4 November 2026 - Sectra (STO: SECT B), a medical imaging IT and cybersecurity company, announced on Wednesday that it has signed a seven-year agreement with Mount Sinai Health System in New York to deploy Sectra Reporting, integrating medical imagin...